Rapid Fire AFib: The Latest in Management Strategies



What You Will Learn

  • Utilize advantages of early rhythm control

  • Optimization and dose adjustments for DOACs

  • Select patients for triple therapy, including duration and optimal agents

  • Identify indications of non-pharmacologic treatment for patients at high risk of bleeding

We are grateful to these distinguished Members of the American College of Cardiology who contributed to this collection:


Julia H. Indik, MD, PhD, FACC (Chair)


James V. Freeman, MD, FACC


Michael Robert Gold, MD, PhD, Facc


Tiffany Ying Hu, MD


Dharam J. Kumbhani, MD, SM, FACC


Nicholas Tan, MD


Cynthia M. Tracy, MD


Supported by an independent educational grant from: Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC | Page Launched: April 2022

Android App Download IOS App Download Powered By